News
01-11-2016, 01:52 AM
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
More... (http://www.news-medical.net/news/20160111/Auranofin-drug-could-improve-prognosis-for-ovarian-cancer-patients-exhibiting-BRCA1-deficiency.aspx)
More... (http://www.news-medical.net/news/20160111/Auranofin-drug-could-improve-prognosis-for-ovarian-cancer-patients-exhibiting-BRCA1-deficiency.aspx)